Thyroid function and nutritional markers TSH (thyroid stimulating hormone) monitoring is recommended for people on semaglutide, primarily because GLP-1 receptor agonists as a drug class have been associated with C-cell hyperplasia in animal studies, which raised theoretical concerns about thyroid cancer risk
This innovative approach makes tirzepatide weight loss superior as it targets two hormonal pathways simultaneously
NICE and MHRA guidance recommend monitoring for gastrointestinal side effects and reporting adverse reactions through the Yellow Card scheme
23431, docket 2026-08552, published May 1, 2026) - removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, with a public comment period through June 2026
In this article, I discuss the definition of liposomes and how to choose the best liposomal supplement and potential side effects
I recently spoke with a client who was stunned by their rising pharmacy spend
